Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

Clinical trial NCT05148845 · UNKNOWN

Trial details

NCT number: NCT05148845
Sponsor: Wits Health Consortium (Pty) Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

SARS CoV 2 Infection

Start date: 2021-11-10
Primary completion: 2022-01-31
Enrollment: 500000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.